Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERENUMAB vs ERYTHROMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERENUMAB vs ERYTHROMYCIN: Safety Overview

Metric ERENUMAB ERYTHROMYCIN
Total FAERS Reports 1,183 7,325
Deaths Reported 363 467
Death Rate 30.7% 6.4%
Hospitalizations 498 1,213
Average Patient Age 45.6 yrs 53.9 yrs
% Female Patients 93.4% 79.8%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Amgen Inc Bryant Ranch Prepack
Route SUBCUTANEOUS TOPICAL
Marketing Status N/A Discontinued